Sevident, Inc.
- UEI
- GLT2SML6NFK8
- CAGE
- 66NV5
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- sevident.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sevident, INC.:1242717 [16-064431] sbir phase i topic | National Cancer Institute (NIH) | $299,338 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel test for the early detection of dengue virus infection | National Institutes of Health | $577,652 |
Quick answers
Is Sevident, Inc. registered in SAM.gov?
Sevident, Inc.'s SAM.gov registration expired on July 21, 2018.
What is Sevident, Inc.'s most recent federal award?
Sevident, Inc.'s most recent federal contract award is Sevident, INC.:1242717 [16-064431] sbir phase i topic (HHSN261201600053C), from National Cancer Institute (NIH), on September 19, 2016.
On GovTribe
See Sevident, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors